Abciximab 10mg
| Product Overview | |
| Generic Name | Abciximab 10mg |
| Brand Name(s) | ReoPro, Faximab |
| Form | IV Injection Sol. |
| Strength | 10 mg/5mL vial |
| Therapeutic Class | Glycoprotein IIb/IIIa inhibitor; antithrombotic |
| ATC Code | B01AC13 |
| Manufacturing & Regulatory | |
| Manufacturer | Lilly, Reliance, Lupin |
| Country | USA/India/Mexico |
| GMP Compliance | FDA/EMA/WHO-GMP |
| DMF/CEP | Type II |
| COFEPRIS | Pending |
| Free Sale Certificate | Yes |
| Logistics & Export | |
| MOQ | 10 vials |
| Shelf Life | 24 months |
| Storage | 2–8 °C, protect from light |
| Incoterms | Ex-works Mex |
| Lead Time | 7 - 10 days |
| Documentation | |
| Certificate of Analysis (COA) | Yes |
| SDS | Upon Request |
| CTD Summary | Upon Request |
Description
Indications/Usage: Acute Coronary Syndrome, Percutaneous Coronary Intervention, ST-Elevation Myocardial Infarction, Thrombosis Prevention
